Search results for "OTHER"

showing 10 items of 12132 documents

MINIMIZING INFLIXIMAB TOXICITY IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

2008

Abstract Background Infliximab is a widely used biological agent for the treatment of inflammatory bowel disease, and has a favorable risk/benefit ratio. Aim It is useful to know that patients treated with infliximab are exposed to developing adverse events that could be reduced with a prudent and a rational clinical approach and by optimizing the treatment protocol. Methods PubMed (including Epub) was searched in October 2006 and again in March 2007. Results The high immunogenic potential of infliximab determines the antibodies that inhibit the effect of infliximab and the appearance of subsequent acute and delayed infusion reactions. Infliximab has an immunomodulatory effect, thus increas…

musculoskeletal diseasesmedicine.medical_specialtyTuberculosisInflammatory bowel diseaseGastroenterologyDrug Administration SchedulePharmacotherapyimmune system diseasesInternal medicinemedicineHumansImmunologic Factorsskin and connective tissue diseasesAdverse effectClinical Trials as TopicHepatologybusiness.industryTumor Necrosis Factor-alphaGastroenterologyAntibodies Monoclonalmedicine.diseaseInflammatory Bowel DiseasesInfliximabInfliximabLymphomastomatognathic diseasesHeart failureToxicityDrug Therapy CombinationbusinessImmunosuppressive Agentsmedicine.drug
researchProduct

OP0015 Induction of remission and maintenance in early, aggressive rheumatoid arthritis using adalimumab in combination with methotrexate with or wit…

2017

Background Remission is the current aim of early RA treatment. In patients with early, aggressive RA, combination with adalimumab (ADA) plus methotrexate (MTX) was superior to either MTX or ADA alone in obtaining clinical remission. Moreover, it has been demonstrated that a short-term aggressive treatment with high-dose glucocorticoids (GC) plus conventional DMARDs lead to long-term (up to 5 years) benefits. Objectives To compare the proportion of patients who achieve remission at 12 months, between two groups of subjects treated with ADA + MTX + high dose GC (intensive) and ADA + MTX + placebo (standard), and to evaluate the proportion of those maintaining remission at 24 months, after dis…

musculoskeletal diseasesmedicine.medical_specialtybusiness.industry030503 health policy & servicesmedicine.diseasePlaceboGastroenterologyDiscontinuationFirst line treatmentDouble blind study03 medical and health sciences0302 clinical medicineimmune system diseasesPrednisoneRheumatoid arthritisInternal medicinemedicineAdalimumabMethotrexate030212 general & internal medicine0305 other medical sciencebusinessmedicine.drug
researchProduct

Juxtacortical mandibular chondrosarcoma during pregnancy : a case report

2017

Chondrosarcoma is one of the most common malignant bone tumors in adults. It use to affect upper arm, pelvis and thigh bone. A wide surgical extirpation represent the gold standard to treat this disorder. In fact, radiotherapy and chemotherapy are no useful. Interestingly, chondrosarcoma is rare in head and neck (HNCS) and extremely uncommon during pregnancy. Thus, there is a lack of evidence about the proper treatment in these cases. A wide surgical extirpation is also considered the most effective procedure in HNCS. There are no consistent evidences about the he role of radiation and chemotherapy. In view of that, the present study describes a case of juxtacortical mandibular chondrosarco…

musculoskeletal diseasesmedicine.medical_specialtymedicine.medical_treatmentCase ReportThigh03 medical and health sciences0302 clinical medicineMedicineGeneral DentistryPelvisChemotherapyPregnancyOral Medicine and Pathologybusiness.industryMultidisciplinary analysisGold standard030206 dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseSurgeryRadiation therapymedicine.anatomical_structure030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASChondrosarcomabusiness
researchProduct

Treatment with a CO-releasing molecule (CORM-3) reduces joint inflammation and erosion in murine collagen-induced arthritis.

2008

Contains fulltext : 70589.pdf (Publisher’s version ) (Closed access) OBJECTIVE: CO-releasing molecules (CO-RMs) are a novel class of anti-inflammatory agents. We have examined the possible therapeutic effects of CORM-3 in collagen-induced arthritis (CIA). METHODS: Arthritis was induced in DBA-1/J mice by type II collagen. Animals were treated with CORM-3 (5 and 10 mg/kg/day, intraperitoneally) or the inactive compound iCORM-3 (10 mg/kg/day, intraperitoneally) unable to release CO, from days 22 to 31. Production of anti-type II collagen antibodies, cytokines and cartilage olimeric matrix protein (COMP) was evaluated by enzyme-linked immunosorbent assay, and prostaglandin E(2) (PGE(2)) by rad…

musculoskeletal diseasesmedicine.medical_treatmentImmunologyAnti-Inflammatory AgentsDrug Evaluation PreclinicalType II collagenArthritisInflammationPharmacologyAuto-immunity transplantation and immunotherapy [N4i 4]DinoprostoneGeneral Biochemistry Genetics and Molecular BiologyMiceRheumatologyOrganometallic CompoundsPerception and Action [DCN 1]medicineAnimalsImmunology and AllergyChronic inflammation and autoimmunity [UMCN 4.2]Dose-Response Relationship Drugbiologybusiness.industryRANK LigandInterleukinIntercellular Adhesion Molecule-1medicine.diseaseArthritis ExperimentalPathogenesis and modulation of inflammation [N4i 1]Cellular infiltrationCyclooxygenase 2Mice Inbred DBARANKLImmunologybiology.proteinCytokinesTumor necrosis factor alphaMicrobial pathogenesis and host defense [UMCN 4.1]Inflammation Mediatorsmedicine.symptombusinessInfection and autoimmunity [NCMLS 1]Heme Oxygenase-1Immunity infection and tissue repair [NCMLS 1]Prostaglandin E
researchProduct

Exercise for the intervertebral disc : a 6-month randomised controlled trial in chronic low back pain

2020

Background context Muscle, bone and tendon respond anabolically to mechanical forces. Whether the intervertebral disc (IVD) can benefit from exercise is unclear. Purpose To examine whether exercise can beneficially affect IVD characteristics. Study design/setting This is a single-blinded 6-month randomised controlled trial (ACTRN12615001270505) in an exercise and physiotherapy clinic. Patient sample Forty patients with chronic non-specific low back pain (NSCLBP) are included in this study. Outcome measures The primary outcome was lumbar IVD T2 time (MRI). Secondary outcomes included IVD diffusion coefficient and IVD expansion with short-duration lying. Methods Twenty patients progressively …

musculoskeletal diseasesnikamavälilevymagneettikuvausphysical activityliikuntamusculoskeletal systemspinefysioterapiarehabilitationselkärankamagnetic resonance imagingkrooninen kipuphysical therapyintervertebral disckuntoutusphysiotherapyfyysinen aktiivisuusliikuntahoito
researchProduct

Postoperative Patient Education in Physiotherapy after Hip Arthroplasty : Patients' Perspective

2017

Objective The objective of the present study was to explore postoperative patient education in physiotherapy from total hip arthroplasty (THA) patients' perspectives, which has been a little‐studied area of research. The usefulness of rehabilitation protocols after THA has been debated over the years, and there are no clear guidelines for physiotherapy after THA Methods The data for the present qualitative study were collected from nine patients with THA by using individual interviews at the hospital after surgery. The interviews were audio‐recorded and analysed by using a phenomenographic method Results Four different categories of postoperative patient education in physiotherapy after hip…

musculoskeletal diseasespatients' perspectivespostoperative patient education in physiotherapyfenomenografiahip arthroplasty
researchProduct

Rhythmic exercises as tools for rehabilitation following cerebellar stroke: A case study integrating music therapy and physiotherapy techniques

2022

Introduction: This article explores the use of music and multisensory stimuli in the construction of compensatory neural networks for motoric functioning in a patient recovering from cerebellar strokes (CS). This study aimed to address the real-world clinical concern of patients having a passive role in therapy, by arousing the client’s interest and self-motivation in rehabilitation. Method: The article presents a case study of a CS survivor, using data derived from rehabilitation sessions combining music therapy techniques with physiotherapy techniques to improve the fluency and accuracy of his motor performance. Qualitative and quantitative data are used to identify, describe, and evaluat…

music therapyspeechmusiikkiterapiaself-generated cuesrhythmrytmifysioterapiacerebellar strokeaivohalvauspuhe (puhuminen)Complementary and alternative medicineArts and Humanities (miscellaneous)Anthropologyneuropsykologinen kuntoutusPshychiatric Mental HealthphysiotherapyNordic Journal of Music Therapy
researchProduct

Mutvārdu vēsture avotu kritikas skatījumā

2019

Kaspara Zeļļa tēzes referātam, kuru viņš nolasīja Latvijas Universitātes 76. starptautiskās zinātniskās konferencē. Tehnisku iemeslu dēļ tēzes netika publicētas LU FSI tēžu un rakstu krājumā "Kritiskā domāšana, inovācija, konkurētspēja un globalizācija", kurš ievietots šajā repozitorijā 2019. gada sākumā.

mutvārdu vēsture:SOCIAL SCIENCES::Other social sciences [Research Subject Categories]avotu kritika
researchProduct

COVID‐19 in older adults: What are the differences with younger patients?

2020

Aim The present study aimed both to gain knowledge on the distinctive clinical characteristics of older adults with coronavirus disease 2019 (COVID‐19), in comparison with those of younger patients, and to identify risk factors for mortality. Methods A retrospective observational study was carried out of patients consecutively admitted to Doctor Peset University Hospital, Valencia (Spain) for COVID‐19 from 11 March to 28 April 2020. Every case was diagnosed by reverse transcription polymerase chain reaction or by serology test to detect antibodies. Demographic details, clinical characteristics, laboratory findings on admission and complications of each case were collected from electronic me…

myalgiaAdultMalemedicine.medical_specialtyAdolescentFevercoronavirusComorbiditySerology03 medical and health scienceschemistry.chemical_compoundYoung Adult0302 clinical medicine030502 gerontologyCOVID‐19Risk FactorsInternal medicinemedicineHumansHospital Mortalityclinical characteristicsolder adultsOxygen saturation (medicine)AgedRetrospective StudiesAged 80 and overCreatininebusiness.industrySARS-CoV-2Medical recordAge FactorsCOVID-19Retrospective cohort studyOdds ratioOriginal ArticlesMiddle AgedmortalityConfidence intervalHospitalizationchemistryCoughSpainORIGINAL ARTICLE: Epidemiology Clinical Practice and HealthFemalemedicine.symptom0305 other medical sciencebusiness030217 neurology & neurosurgeryGeriatrics & Gerontology International
researchProduct

Management of Statin Intolerance in 2018: Still More Questions Than Answers.

2018

Statin therapy is generally well tolerated and very effective in the prevention and treatment of cardiovascular disease, regardless of cholesterol levels; however, it can be associated with various adverse events (myalgia, myopathy, rhabdomyolysis, and diabetes mellitus, among others). Patients frequently discontinue statin therapy without medical advice because of perceived side effects and consequently increase their risk for cardiovascular events. In patients with statin intolerance, it may be advisable to change the dose, switch to a different statin, or try an alternate-day regimen. If intolerance is associated with all statins—even at the lowest dose—non-statin drugs and certain nutra…

myalgiamedicine.medical_specialtyStatinDrug-Related Side Effects and Adverse Reactionsmedicine.drug_classDiseaseReview Article030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicinePharmacotherapyMedical adviceDiabetes mellitusCardiovascular DiseasemedicineHumansPharmacology (medical)030212 general & internal medicinecardiovascular diseasesAdverse effectIntensive care medicineDietary SupplementHypolipidemic AgentsHypolipidemic Agentbusiness.industrynutritional and metabolic diseasesDisease ManagementGeneral MedicineCholesterol LDLmedicine.diseaseRegimenCardiovascular DiseasesDietary Supplementslipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase Inhibitormedicine.symptomHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessDrug-Related Side Effects and Adverse ReactionHumanAmerican journal of cardiovascular drugs : drugs, devices, and other interventions
researchProduct